Posted on August 25, 20258/25/25
Evaluation of HTA Frameworks for In Vivo Diagnostics: Assessing Methodological Gaps and Implications for Market Access
Posted on August 22, 20258/22/25
Navigating MFN: Alan Crowther on What Pharma Brands Must Know Now
Posted on July 22, 20257/22/25
Case Study: Transforming Market Access with NAVLIN Insights KPI
Posted on July 15, 20257/15/25
Where Process Meets Profit: How Strategic Order to Cash Drives Real Revenue Outcomes
Posted on May 23, 20255/23/25
Most Favored Nation Pricing | Insights and Implications for Manufacturers
Posted on May 3, 20255/3/25
One Team, One Voice: The Impact of Centralized Medical Content Development
Posted on April 11, 20254/11/25
Unlocking Pharma Success: Mike Ryan’s Pre-Conference Talk at Reuters Pharma 2025
Posted on April 4, 20254/4/25
CASE STUDY: Transforming Clinical Trials with EVERSANA
Posted on March 19, 20253/19/25
Maximizing Sales with AI: A Strategic Roadmap for Success
Posted on March 19, 20253/19/25